KSR1: A Potential Drug Target and Biomarker for Ras-Induced Progress

Target Name: KSR1

NCBI ID: G8844

KSR1

KSR1: A Potential Drug Target and Biomarker for Ras-Induced Progress

The RAS/MAPK signaling pathway is a crucial factor in various cellular processes, including cell growth, differentiation, and survival. The RAS gene is a key regulator of this pathway and is involved in the formation of the RAS-MAPK complex, which plays a central role in the signaling pathway. The kinase suppressor of Ras (KSR1) is a protein that can inhibit the activity of the RAS gene and has been identified as a potential drug target and biomarker for various diseases.

KSR1 is a 21-kDa protein that is expressed in various tissues and cells. It is a N-terminal kinase inhibitor that can inhibit the activity of the RAS gene by a unique mechanism. KSR1 has been shown to be able to inhibit the activity of both the wild-type and mutant RAS genes, indicating that it has a broad inhibitory effect on the RAS/MAPK signaling pathway.

KSR1 has been shown to have various physiological functions, including the regulation of cell growth, the control of cell differentiation, and the regulation of cell survival. For example, KSR1 has been shown to inhibit the migration of cancer cells and to promote the inhibition of cell proliferation in various types of cancer cells. It has also been shown to play a role in the regulation of the immune response and to have a role in the regulation of the blood-brain barrier.

In addition to its physiological functions, KSR1 has also been shown to be a potential drug target. The RAS/MAPK signaling pathway is a highly validated drug target, and various inhibitors of this pathway have been developed and are in use for the treatment of various diseases. The development of KSR1 as a potential drug target is based on its ability to inhibit the activity of the RAS gene and its potential to have a wide range of physiological effects.

KSR1 has been shown to be able to inhibit the activity of both the wild-type and mutant RAS genes, indicating that it has a broad inhibitory effect on the RAS/MAPK signaling pathway. This means that KSR1 can be used as a potential drug to inhibit the activity of the RAS gene and prevent the formation of the RAS-MAPK complex.

In conclusion, KSR1 is a protein that has been shown to have various physiological functions, including the regulation of cell growth, the control of cell differentiation, and the regulation of cell survival. It is also a potential drug target and biomarker for various diseases due to its ability to inhibit the RAS/MAPK signaling pathway. Further research is needed to fully understand the potential clinical applications of KSR1 and to develop safe and effective drugs that can be used to treat various diseases.

Protein Name: Kinase Suppressor Of Ras 1

Functions: Part of a multiprotein signaling complex which promotes phosphorylation of Raf family members and activation of downstream MAP kinases (By similarity). Independently of its kinase activity, acts as MAP2K1/MEK1 and MAP2K2/MEK2-dependent allosteric activator of BRAF; upon binding to MAP2K1/MEK1 or MAP2K2/MEK2, dimerizes with BRAF and promotes BRAF-mediated phosphorylation of MAP2K1/MEK1 and/or MAP2K2/MEK2 (PubMed:29433126). Promotes activation of MAPK1 and/or MAPK3, both in response to EGF and to cAMP (By similarity). Its kinase activity is unsure (By similarity). Some protein kinase activity has been detected in vitro, however the physiological relevance of this activity is unknown (By similarity)

The "KSR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KSR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets